Home » Topics » Regulatory » Patents

Patents
RSS

Rudong SIMR Biotech identifies novel GABRA5 inverse agonists

Nov. 20, 2017

Genoscience Pharma presents compounds for treating cancer

Nov. 20, 2017

Amgen presents novel apelin receptor agonists

Nov. 17, 2017

Shanghai De Novo Pharmatech has presented TLR8 agonists

Nov. 17, 2017

GlaxoSmithKline discloses novel EZH2 inhibitors

Nov. 17, 2017

Bayer discovers new vasopressin receptor antagonists

Nov. 17, 2017

OncoArendi Therapeutics patents arginase inhibitors

Nov. 17, 2017

Rudong SIMR Biotech presents new GABRA5 inverse agonists

Nov. 16, 2017

Inception 1 discovers novel NADPH oxidase 4 inhibitors

Nov. 16, 2017

Novel vasopressin V1A and V2 receptor antagonists developed at Bayer

Nov. 16, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...